20-62952880-A-G

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_022082.4(SLC17A9):ā€‹c.50A>Gā€‹(p.Gln17Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000207 in 964,538 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.00015 ( 0 hom., cov: 0)
Exomes š‘“: 0.000013 ( 0 hom. )

Consequence

SLC17A9
NM_022082.4 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.03
Variant links:
Genes affected
SLC17A9 (HGNC:16192): (solute carrier family 17 member 9) This gene encodes a member of a family of transmembrane proteins that are involved in the transport of small molecules. The encoded protein participates in the vesicular uptake, storage, and secretion of adenoside triphosphate (ATP) and other nucleotides. A mutation in this gene was found in individuals with autosomal dominant disseminated superficial actinic porokeratosis-8. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.049886197).
BS2
High AC in GnomAd4 at 8 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SLC17A9NM_022082.4 linkuse as main transcriptc.50A>G p.Gln17Arg missense_variant 1/13 ENST00000370351.9 NP_071365.4
SLC17A9NM_001302643.2 linkuse as main transcriptc.-31A>G 5_prime_UTR_variant 1/14 NP_001289572.2
SLC17A9XR_936601.4 linkuse as main transcriptn.172A>G non_coding_transcript_exon_variant 1/10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SLC17A9ENST00000370351.9 linkuse as main transcriptc.50A>G p.Gln17Arg missense_variant 1/131 NM_022082.4 ENSP00000359376 P1Q9BYT1-1
SLC17A9ENST00000370349.7 linkuse as main transcriptc.-31A>G 5_prime_UTR_variant 1/141 ENSP00000359374 Q9BYT1-2
SLC17A9ENST00000488738.5 linkuse as main transcriptn.170A>G non_coding_transcript_exon_variant 1/112

Frequencies

GnomAD3 genomes
AF:
0.000133
AC:
7
AN:
52576
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.000464
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000355
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000295
AC:
3
AN:
101790
Hom.:
0
AF XY:
0.0000362
AC XY:
2
AN XY:
55242
show subpopulations
Gnomad AFR exome
AF:
0.000160
Gnomad AMR exome
AF:
0.000108
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000132
AC:
12
AN:
911934
Hom.:
0
Cov.:
35
AF XY:
0.0000157
AC XY:
7
AN XY:
446634
show subpopulations
Gnomad4 AFR exome
AF:
0.000299
Gnomad4 AMR exome
AF:
0.0000882
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000409
Gnomad4 OTH exome
AF:
0.0000304
GnomAD4 genome
AF:
0.000152
AC:
8
AN:
52604
Hom.:
0
Cov.:
0
AF XY:
0.000122
AC XY:
3
AN XY:
24608
show subpopulations
Gnomad4 AFR
AF:
0.000540
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000355
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000843
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 22, 2022The c.50A>G (p.Q17R) alteration is located in exon 1 (coding exon 1) of the SLC17A9 gene. This alteration results from a A to G substitution at nucleotide position 50, causing the glutamine (Q) at amino acid position 17 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
5.2
DANN
Benign
0.66
DEOGEN2
Benign
0.051
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.053
N
LIST_S2
Benign
0.35
T
M_CAP
Uncertain
0.25
D
MetaRNN
Benign
0.050
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.2
L
MutationTaster
Benign
1.0
D;N
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-0.79
N
REVEL
Benign
0.022
Sift
Benign
0.41
T
Sift4G
Benign
0.39
T
Polyphen
0.0
B
Vest4
0.078
MutPred
0.31
Loss of catalytic residue at Q17 (P = 0.042);
MVP
0.040
MPC
0.46
ClinPred
0.019
T
GERP RS
-0.76
Varity_R
0.039
gMVP
0.072

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs560535105; hg19: chr20-61584232; API